Autosomal recessive nonsyndromic hearing loss (ARNSHL) is a genetically heterogeneous sensorineural disorder, generally manifested with prelingual hearing loss and absence of other clinical manifestations. The aim of this study is to identify the pathogenic gene in a four-generation consanguineous Chinese family with ARNSHL. A novel homozygous variant, c.9316dupC (p.H3106Pfs*2), in the myoxin XVa gene (MYO15A) was identified by exome sequencing and Sanger sequencing. The homozygous MYO15A c.9316dupC variant co-segregated with the phenotypes in the ARNSHL family and was absent in two hundred normal controls. The variant was predicted to interfere with the formation of the Myosin XVa-whirlin-Eps8 complex at the tip of stereocilia, which is indispensable for stereocilia elongation. Our data suggest that the homozygous MYO15A c.9316dupC variant might be the pathogenic mutation, and exome sequencing is a powerful molecular diagnostic strategy for ARNSHL, an extremely heterogeneous disorder. Our findings extend the mutation spectrum of the MYO15A gene and have important implications for genetic counseling for the family.
Citation: Xia H, Huang X, Guo Y, Hu P, He G, Deng X, et al. (2015) Identification of a Novel MYO15A Mutation in a Chinese Family with Autosomal Recessive Nonsyndromic Hearing Loss. PLoS ONE 10(8): e0136306. https://doi.org/10.1371/journal.pone.0136306
Editor: Mathias Toft, Oslo University Hospital, NORWAY
Received: June 12, 2015; Accepted: August 2, 2015; Published: August 26, 2015
Copyright: © 2015 Xia et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Data Availability: All relevant data are available within the paper.
Funding: This work was supported by grants from National Natural Science Foundation of China (81271921 and 81441033), Hunan Provincial Innovation Foundation for Postgraduate, China (7138000008), and the Top-notch Innovative Doctoral Scholarship of Central South University, China (2014bjjxj039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Congenital or prelingual hearing loss is a common sensorineural disorder, with a prevalence of about one in 500–1,000 at birth, and at least half of the cases are caused by genetic factors [1,2]. At least 70% of the cases manifest with isolated hearing loss without other associated clinical features, which is classified as nonsyndromic deafness . Hereditary hearing loss mainly displays autosomal recessive or autosomal dominant transmission , and X-linked  or mitochondrial inheritance  is occasionally reported. Most of hereditary deafness manifests as autosomal recessive nonsyndromic hearing loss (ARNSHL) .
ARNSHL is an extremely heterogeneous disease, generally manifested with congenital or prelingual hearing loss without associated clinical symptoms, though postlingual hearing loss has also been reported [2,6]. The individuals with early-onset deafness often encounter obstacles for linguistic development . Since identification of the gap junction protein beta-2 gene (GJB2) as the disease gene for ARNSHL , more than 42 genes have been identified and at least 1,949 pathogenic variants have been reported . Mutations in these genes affect cochlear homeostasis, cellular organization, neuronal transmission, cell growth, differentiation and survival, and tectorial membrane associated proteins . Cochlear implantation has been reported to offer satisfactory auditory performance to patients with severe to profound deafness caused by mutations in the GJB2 gene, the solute carrier family 26 member 4 gene (SLC26A4), the otoferlin gene (OTOF) , or the myosin XVa gene (MYO15A) . Genetic diagnosis plays an important role in prognosis evaluation, clinical management, and prenatal diagnosis for ARNSHL families .
It is difficult to identify causative mutations using regular Sanger sequencing because of high heterogeneity of ARNSHL. Recently, exome sequencing has been introduced and confirmed as an effective alternative strategy . In this study, a novel homozygous mutation in the MYO15A gene was identified in a Chinese ARNSHL family by exome sequencing.
Materials and Methods
A four-generation consanguineous Chinese Han family with ARNSHL was recruited, and four members of the family participated in this study. Bilateral prelingual deafness was observed in the two siblings (IV:1 and IV:2, Fig 1A), who received neither hearing aids nor cochlear implantation in their childhood. However, their parents (III:1 and III:2, Fig 1A) had normal hearing. Two hundred ethnically-matched unrelated subjects (age 29.5±6.5 years) with normal hearing were enrolled as controls. Clinical and audiometric assessments were performed, and peripheral blood samples were collected from all the subjects after obtaining written informed consent from the participants or guardians. The study was approved by the Institutional Review Board of the Third Xiangya Hospital, Central South University, China.
(A) Pedigree of the ARNSHL family. N, normal; M, the MYO15A c.9316dupC variant. (B) The homozygous MYO15A c.9316dupC variant of the affected individual (IV:2). (C) The heterozygous MYO15A c.9316dupC variant of the unaffected individual (III:1). (D) The MYO15A gene sequence of a normal control. ARNSHL, autosomal recessive nonsyndromic hearing loss; MYO15A, the myosin XVa gene.
Clinical and audiometric assessments were performed on the subjects of the family in the Third Xiangya Hospital, Changsha. Pure tone audiometry (PTA), tympanometry, acoustic reflex (AR) thresholds, auditory brainstem responses (ABR), transient evoked otoacoustic emission (TEOAE) and distortion product otoacoustic emission (DPOAE) were conducted. Magnetic resonance imaging (MRI) was carried out to exclude congenital inner ear malformations. The hearing level was assessed at 250, 500, 1000, 2000, 4000 and 8000 Hz by PTA, and sorted into normal (<20 dBHL), mild (20–40 dBHL), moderate (41–70 dBHL), severe (71–95 dBHL), and profound (>95 dBHL) deafness .
Whole exome sequencing and variant analysis
Genomic DNA was extracted from peripheral blood samples of all the subjects using standard phenol-chloroform extraction method . Exome sequencing was conducted by Novogene Bioinformatics Institute, Beijing, China. At least 1.5 micrograms (μg) of genomic DNA from the proband (IV:2, Fig 1A) was sheared by Covaris sonicators, and was enriched, hybridized, and captured on the Agilent SureSelect Human All Exon V5, following the manufacturers’ procedures. The captured library was sequenced with the Illumina HiSeq 2000 sequencing instruments. The average sequencing depth of 57.36× provided enough depth to exactly call variants at 97.4% of targeted exome .
The clean reads without adapter or debased reads were mapped to the human reference genome (UCSC hg19, http://genome.ucsc.edu/) using Burrows-Wheeler Alignment tool (BWA) [17,18]. Single nucleotide polymorphisms (SNPs) and insertions/deletions were identified by the Sequence Alignment/Map tools (SAMtools) , and then Picard was applied to mark duplicate reads. All variants were screened with the SNP database version 142 (dbSNP142), 1000 Genomes Project (version 2014 October), and NHLBI Exome Sequencing Project (ESP) 6500. Functional prediction was carried out by Sorting Intolerant from Tolerant (SIFT) and Polymorphism Phenotyping version 2 (PolyPhen-2). Candidate variants were annotated by the ANNOVAR (Annotate Variation) software .
Direct Sanger sequencing and functional prediction
Direct Sanger sequencing was performed to confirm potential causative variants in the family with ABI3500 sequencer (Applied Biosystems, Foster City, CA, USA) . Primer sequences for pathogenic variant in the MYO15A gene (NM_016239.3) were designed as follows: 5′-TGCCCACCCTGTTCTTATGT -3′ and 5′-ACTCACTGCTTGGAGCTGGT-3′. MutationTaster was applied to the functional prediction of the MYO15A pathogenic variant .
Both patients (IV:1 and IV:2, Fig 1A) presented with deafness and dumbness. Bilateral profound sensorineural hearing loss with thresholds over 95 dBHL was revealed by PTA. Type A tympanometric curve was shown by acoustic immitance measurement, and no inner ear anomaly was discovered by MRI in the two patients. The ABR at 97 dB, AR, TEOAE and DPOAE were absent in both ears of the proband (IV:2, Fig 1A) and the right ear of the elder sibling (IV:1, Fig 1A), while the waves I, III and V of ABR were elicited at 80 dB, remarkably elevated acoustic reflex threshold (80–105 dB) was recorded, and low amplitude DPOAE was elicited at 500, 1000 and 4000 Hz in the left ear of the IV:1 patient, which suggested that some residual hearing might exist in the left ear of the IV:1 patient. The clinical information of the ARNSHL family was summarized in Table 1.
A total of 19,816,364 pairs of sequenced reads with the average read length of 125 bp were generated by exome sequencing, and 98.76% (19,569,878) of sequenced reads passed the quality assessment and were mapped to 99.81% of the human reference genome . Known variants identified in dbSNP142 with minor allele frequency (MAF) >1%, 1000 Genomes Project with a frequency of >0.5%, and NHLBI ESP6500 were filtered out. PolyPhen-2 and SIFT were applied to predict functional effects of non-synonymous SNPs. Subsequently, a homozygous MYO15A c.9316dupC variant was observed in the proband (IV:2, Fig 1A and 1B) and other possible pathogenic mutations for ARNSHL were excluded.
Identification of pathogenic mutation
The homozygous MYO15A c.9316dupC variant was confirmed by Sanger sequencing. The same homozygous MYO15A variant was also detected in his affected sibling (IV:1, Fig 1A), and the heterozygous MYO15A c.9316dupC variant was identified in both of his unaffected parents (III:1 and III:2, Fig 1A and 1C). However, the variant was absent in two hundred ethnically-matched unrelated controls (Fig 1D). The homozygous MYO15A c.9316dupC variant, which co-segregated with the phenotype of deafness and dumbness in the family, and was predicted to lead to a shift in the reading frame at amino acid position 3106 and a premature stop codon (p.H3106Pfs*2) by MutationTaster , might be the disease-causing mutation in the ARNSHL family.
In 1995, a disease gene locus (deafness, autosomal recessive 3; DFNB3) for ARNSHL was first mapped to chromosome 17p-17q12 by linkage analysis of two large multi-generation families from Bengkala, Bali , and then was further refined to chromosome 17p11.2 . In 1998, the homozygous p.N2111Y, p.I2113F and p.K2601* (previously known as p.N890Y, p.I892F and p.K1300*) mutations in the MYO15A gene were identified in three unrelated DFNB3 families [25,26]. A hemizygous p.T2205I mutation of the MYO15A gene was also reported to be associated with moderately severe hearing loss in a Smith-Magenis syndrome (del(17)p11.2) patient .
Homozygous MYO15A mutations cause 6.2% of ARNSHL in Turkey , and mutations in the MYO15A gene account for no less than 5% of autosomal recessive profound hearing loss in Pakistan . To date, at least 86 pathogenic variants of the MYO15A gene have been reported in deafness populations [3,11,26–47], which are summarized in Fig 2. The p.D2720H mutation in the MYO15A gene is considered as a founder mutation in Pakistan , and the p.R1937Tfs*10 and p.S3335Afs*121 mutations in the MYO15A gene were also identified as founder mutations in Turkish population . Most mutations in the MYO15A gene are connected with congenital severe to profound sensorineural deafness [27,46], while some patients also display progressive hearing loss [11,36]. Intriguingly, a homozygous p.Y289* mutation in the MYO15A gene was associated with maintenance of considerable residual hearing in two Turkish patients . High frequency hearing loss or retention of some hearing at low frequency was also reported in patients with MYO15A mutations [11,46].
The myosin XVa consists of 3530 amino acids, including an N-terminal extension domain and Motor domain, two light chain binding IQ motifs, two myosin-tail homology 4 (MyTH4) domains and band 4.1/ezrin/radixin/moesin (FERM) domains, a Src-homology-3 (SH3) domain and a C-terminal class I PDZ-ligand domain. The novel MYO15A mutation in this study is showed with red box at the bottom of the figure, and previously reported mutations are displayed at the top of the figure. MYO15A, the myosin XVa gene.
The MYO15A gene contains 66 exons and encodes several alternatively spliced transcripts in the inner ear . The complete transcript consists of 3530 amino acids, including a long N-terminal extension encoded by exon 2, an N-terminal motor domain, two light chain binding IQ motifs, and a tail region containing two myosin-tail homology 4 (MyTH4) domains, two band 4.1/ezrin/radixin/moesin (FERM) domains, a Src-homology-3 (SH3) domain and a C-terminal class I PDZ-ligand domain [25,48]. Myosin XVa protein is mainly expressed in the cuticular plate and stereocilia of the cochlear inner and outer hair cells , and is commonly localized at the tips of inner ear sensory cell stereocilia . Myosin XVa is involved in staircase formation of the hair bundle, which is indispensable to sound detecting and head movement [48,49].
Homozygous p.C1779Y mutation in the Myo15 gene, a murine homologue of the human MYO15A gene, cause profound sensorineural deafness, vestibular defects, and extremely short stereocilia on the inner and outer hair cells in shaker-2 mice .
In this study, the homozygous c.9316dupC variant in the MYO15A gene was identified in the two affected siblings, but was absent in the unaffected parents and two hundred normal controls. The homozygous c.9316dupC variant in the MYO15A gene co-segregated with the phenotype of deafness in the ARNSHL family and might be the disease-causing mutation.
Both affected siblings display bilateral prelingual, profound sensorineural hearing loss, in accordance with most MYO15A-associated ARNSHL phenotypes . Their language acquisitions were hindered by profound prelingual deafness , thus they also present with dumbness phenotypes. The audiometric tests of the IV:1 patient implied that the patient might have some residual hearing, consistent with the previous report .
The novel c.9316dupC variant in the MYO15A gene, located in the second MyTH4 domain , was predicted to result in a shift in the reading frame and a premature stop codon (p.H3106Pfs*2) by MutationTaster , which leads to a truncated protein missing part of the second MyTH4 domain, the second FERM domain and PDZ-ligand in the tail region of myosin XVa (Fig 2). More than ten mutations have been reported in the second MyTH4 and FERM domain of myosin XVa (summarized in Fig 2). The MyTH4-FERM region is involved in formation of the Myosin XVa-whirlin-Eps8 complex  and microtubule binding . Thus, the c.9316dupC variant in the MYO15A gene might interfere with formation of the Myosin XVa-whirlin-Eps8 complex, which is indispensable for stereocilia elongation and sound detecting [48,51].
The homozygous c.9316dupC variant in the MYO15A gene was the pathogenic mutation in our ARNSHL family. Our study demonstrated that exome sequencing is a powerful molecular diagnostic strategy for ARNSHL, an extremely heterogeneous genetic disorder. Our findings extend the mutation spectrum of the MYO15A gene, and have implication in genetic counseling for the ARNSHL family.
The authors are grateful to the participating individuals and investigators for their co-operation and efforts in collecting clinical and genetic information and DNA specimens.
Conceived and designed the experiments: HD HX. Performed the experiments: HD HX HBX XD ZJY. Analyzed the data: HD HX XJH YG PZH HBX. Contributed reagents/materials/analysis tools: HD HX XJH YG PZH GXH. Wrote the paper: HD HX.
- 1. Mahdieh N, Shirkavand A, Rabbani B, Tekin M, Akbari B, Akbari MT, et al. Screening of OTOF mutations in Iran: a novel mutation and review. Int J Pediatr Otorhinolaryngol. 2012; 76: 1610–1615. pmid:22906306
- 2. Duman D, Tekin M. Autosomal recessive nonsyndromic deafness genes: a review. Front Biosci (Landmark Ed). 2012; 17: 2213–2236.
- 3. Cengiz FB, Duman D, Sirmaci A, Tokgoz-Yilmaz S, Erbek S, Ozturkmen-Akay H, et al. Recurrent and private MYO15A mutations are associated with deafness in the Turkish population. Genet Test Mol Biomarkers. 2010; 14: 543–550. pmid:20642360
- 4. Stanton SG, Griffin A, Stockley TL, Brown C, Young TL, Benteau T, et al. X-linked hearing loss: two gene mutation examples provide generalizable implications for clinical care. Am J Audiol. 2014; 23: 190–200. pmid:24687041
- 5. Wang Q, Li R, Zhao H, Peters JL, Liu Q, Yang L, et al. Clinical and molecular characterization of a Chinese patient with auditory neuropathy associated with mitochondrial 12S rRNA T1095C mutation. Am J Med Genet A. 2005; 133A: 27–30. pmid:15637703
- 6. Hoefsloot LH, Feenstra I, Kunst HP, Kremer H. Genotype phenotype correlations for hearing impairment: approaches to management. Clinical Genetics. 2014; 85: 514–523. pmid:24547994
- 7. Dror AA, Avraham KB. Hearing impairment: a panoply of genes and functions. Neuron. 2010; 68: 293–308. pmid:20955936
- 8. Kelsell DP, Dunlop J, Stevens HP, Lench NJ, Liang JN, Parry G, et al. Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature. 1997; 387: 80–83. pmid:9139825
- 9. Shearer AE, Eppsteiner RW, Booth KT, Ephraim SS, Gurrola JN, Simpson A, et al. Utilizing ethnic-specific differences in minor allele frequency to recategorize reported pathogenic deafness variants. American Journal of Human Genetics. 2014; 95: 445–453. pmid:25262649
- 10. Wu CC, Liu TC, Wang SH, Hsu CJ, Wu CM. Genetic characteristics in children with cochlear implants and the corresponding auditory performance. Laryngoscope. 2011; 121: 1287–1293. pmid:21557232
- 11. Miyagawa M, Nishio SY, Hattori M, Moteki H, Kobayashi Y, Sato H, et al. Mutations in the MYO15A Gene Are a Significant Cause of Nonsyndromic Hearing Loss: Massively Parallel DNA Sequencing-Based Analysis. Ann Otol Rhinol Laryngol. 2015; 124: 158S–168S. pmid:25792667
- 12. Chang MY, Choi BY. Strategy for the customized mass screening of genetic sensorineural hearing loss in koreans. Korean J Audiol. 2014; 18: 45–49. pmid:25279224
- 13. Diaz-Horta O, Duman D, Foster JN, Sirmaci A, Gonzalez M, Mahdieh N, et al. Whole-exome sequencing efficiently detects rare mutations in autosomal recessive nonsyndromic hearing loss. PLoS One. 2012; 7: e50628. pmid:23226338
- 14. Bae SH, Baek JI, Lee JD, Song MH, Kwon TJ, Oh SK, et al. Genetic analysis of auditory neuropathy spectrum disorder in the Korean population. Gene. 2013; 522: 65–69. pmid:23562982
- 15. Zheng W, Deng X, Liang H, Song Z, Gao K, Yang Y, et al. Genetic analysis of the fused in sarcoma gene in Chinese Han patients with essential tremor. Neurobiology of Aging. 2013; 34: 2073–2078.
- 16. Yuan L, Wu S, Xu H, Xiao J, Yang Z, Xia H, et al. Identification of a novel PHEX mutation in a Chinese family with X-linked hypophosphatemic rickets using exome sequencing. Biological Chemistry. 2015; 396: 27–33. pmid:25060345
- 17. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009; 25: 1754–1760. pmid:19451168
- 18. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The human genome browser at UCSC. Genome Research. 2002; 12: 996–1006. pmid:12045153
- 19. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009; 25: 2078–2079. pmid:19505943
- 20. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Research. 2010; 38: e164. pmid:20601685
- 21. Guo Y, Yang H, Deng X, Song Z, Yang Z, Xiong W, et al. Genetic analysis of the S100B gene in Chinese patients with Parkinson disease. Neuroscience Letters. 2013; 555: 134–136. pmid:24076007
- 22. Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014; 11: 361–362. pmid:24681721
- 23. Friedman TB, Liang Y, Weber JL, Hinnant JT, Barber TD, Winata S, et al. A gene for congenital, recessive deafness DFNB3 maps to the pericentromeric region of chromosome 17. Nature Genetics. 1995; 9: 86–91. pmid:7704031
- 24. Liang Y, Wang A, Probst FJ, Arhya IN, Barber TD, Chen KS, et al. Genetic mapping refines DFNB3 to 17p11.2, suggests multiple alleles of DFNB3, and supports homology to the mouse model shaker-2. American Journal of Human Genetics. 1998; 62: 904–915. pmid:9529344
- 25. Liang Y, Wang A, Belyantseva IA, Anderson DW, Probst FJ, Barber TD, et al. Characterization of the human and mouse unconventional myosin XV genes responsible for hereditary deafness DFNB3 and shaker 2. Genomics. 1999; 61: 243–258. pmid:10552926
- 26. Wang A, Liang Y, Fridell RA, Probst FJ, Wilcox ER, Touchman JW, et al. Association of unconventional myosin MYO15 mutations with human nonsyndromic deafness DFNB3. Science. 1998; 280: 1447–1451. pmid:9603736
- 27. Liburd N, Ghosh M, Riazuddin S, Naz S, Khan S, Ahmed Z, et al. Novel mutations of MYO15A associated with profound deafness in consanguineous families and moderately severe hearing loss in a patient with Smith-Magenis syndrome. Human Genetics. 2001; 109: 535–541. pmid:11735029
- 28. Gu X, Guo L, Ji H, Sun S, Chai R, Wang L, et al. Genetic testing for sporadic hearing loss using targeted massively parallel sequencing identifies 10 novel mutations. Clinical Genetics. 2015; 87: 588–593. pmid:24853665
- 29. Shafique S, Siddiqi S, Schraders M, Oostrik J, Ayub H, Bilal A, et al. Genetic spectrum of autosomal recessive non-syndromic hearing loss in Pakistani families. PLoS One. 2014; 9: e100146. pmid:24949729
- 30. Brownstein Z, Abu-Rayyan A, Karfunkel-Doron D, Sirigu S, Davidov B, Shohat M, et al. Novel myosin mutations for hereditary hearing loss revealed by targeted genomic capture and massively parallel sequencing. European Journal of Human Genetics. 2014; 22: 768–775. pmid:24105371
- 31. Riahi Z, Bonnet C, Zainine R, Louha M, Bouyacoub Y, Laroussi N, et al. Whole exome sequencing identifies new causative mutations in Tunisian families with non-syndromic deafness. PLoS One. 2014; 9: e99797. pmid:24926664
- 32. Gao X, Zhu QY, Song YS, Wang GJ, Yuan YY, Xin F, et al. Novel compound heterozygous mutations in the MYO15A gene in autosomal recessive hearing loss identified by whole-exome sequencing. J Transl Med. 2013; 11: 284. pmid:24206587
- 33. Miyagawa M, Naito T, Nishio SY, Kamatani N, Usami S. Targeted exon sequencing successfully discovers rare causative genes and clarifies the molecular epidemiology of Japanese deafness patients. PLoS One. 2013; 8: e71381. pmid:23967202
- 34. Woo HM, Park HJ, Baek JI, Park MH, Kim UK, Sagong B, et al. Whole-exome sequencing identifies MYO15A mutations as a cause of autosomal recessive nonsyndromic hearing loss in Korean families. BMC Med Genet. 2013; 14: 72. pmid:23865914
- 35. Yang T, Wei X, Chai Y, Li L, Wu H. Genetic etiology study of the non-syndromic deafness in Chinese Hans by targeted next-generation sequencing. Orphanet J Rare Dis. 2013; 8: 85. pmid:23767834
- 36. Miyagawa M, Nishio SY, Ikeda T, Fukushima K, Usami S. Massively parallel DNA sequencing successfully identifies new causative mutations in deafness genes in patients with cochlear implantation and EAS. PLoS One. 2013; 8: e75793. pmid:24130743
- 37. Fattahi Z, Shearer AE, Babanejad M, Bazazzadegan N, Almadani SN, Nikzat N, et al. Screening for MYO15A gene mutations in autosomal recessive nonsyndromic, GJB2 negative Iranian deaf population. Am J Med Genet A. 2012; 158A: 1857–1864. pmid:22736430
- 38. Bashir R, Fatima A, Naz S. Prioritized sequencing of the second exon of MYO15A reveals a new mutation segregating in a Pakistani family with moderate to severe hearing loss. Eur J Med Genet. 2012; 55: 99–102. pmid:22245518
- 39. Brownstein Z, Friedman LM, Shahin H, Oron-Karni V, Kol N, Abu RA, et al. Targeted genomic capture and massively parallel sequencing to identify genes for hereditary hearing loss in Middle Eastern families. Genome Biol. 2011; 12: R89. pmid:21917145
- 40. Duman D, Sirmaci A, Cengiz FB, Ozdag H, Tekin M. Screening of 38 genes identifies mutations in 62% of families with nonsyndromic deafness in Turkey. Genet Test Mol Biomarkers. 2011; 15: 29–33. pmid:21117948
- 41. Imtiaz F, Taibah K, Ramzan K, Bin-Khamis G, Kennedy S, Al-Mubarak B, et al. A comprehensive introduction to the genetic basis of non-syndromic hearing loss in the Saudi Arabian population. BMC Med Genet. 2011; 12: 91. pmid:21726435
- 42. Belguith H, Aifa-Hmani M, Dhouib H, Said MB, Mosrati MA, Lahmar I, et al. Screening of the DFNB3 locus: identification of three novel mutations of MYO15A associated with hearing loss and further suggestion for two distinctive genes on this locus. Genet Test Mol Biomarkers. 2009; 13: 147–151. pmid:19309289
- 43. Shearer AE, Hildebrand MS, Webster JA, Kahrizi K, Meyer NC, Jalalvand K, et al. Mutations in the first MyTH4 domain of MYO15A are a common cause of DFNB3 hearing loss. Laryngoscope. 2009; 119: 727–733. pmid:19274735
- 44. Lezirovitz K, Pardono E, de Mello AM, de Carvalho ESF, Lopes JJ, Abreu-Silva RS, et al. Unexpected genetic heterogeneity in a large consanguineous Brazilian pedigree presenting deafness. European Journal of Human Genetics. 2008; 16: 89–96. pmid:17851452
- 45. Kalay E, Uzumcu A, Krieger E, Caylan R, Uyguner O, Ulubil-Emiroglu M, et al. MYO15A (DFNB3) mutations in Turkish hearing loss families and functional modeling of a novel motor domain mutation. Am J Med Genet A. 2007; 143A: 2382–2389. pmid:17853461
- 46. Nal N, Ahmed ZM, Erkal E, Alper OM, Luleci G, Dinc O, et al. Mutational spectrum of MYO15A: the large N-terminal extension of myosin XVA is required for hearing. Human Mutation. 2007; 28: 1014–1019. pmid:17546645
- 47. Shahin H, Walsh T, Rayyan AA, Lee MK, Higgins J, Dickel D, et al. Five novel loci for inherited hearing loss mapped by SNP-based homozygosity profiles in Palestinian families. European Journal of Human Genetics. 2010; 18: 407–413. pmid:19888295
- 48. Belyantseva IA, Boger ET, Naz S, Frolenkov GI, Sellers JR, Ahmed ZM, et al. Myosin-XVa is required for tip localization of whirlin and differential elongation of hair-cell stereocilia. Nature Cell Biology. 2005; 7: 148–156. pmid:15654330
- 49. Belyantseva IA, Boger ET, Friedman TB. Myosin XVa localizes to the tips of inner ear sensory cell stereocilia and is essential for staircase formation of the hair bundle. Proc Natl Acad Sci U S A. 2003; 100: 13958–13963. pmid:14610277
- 50. Probst FJ, Fridell RA, Raphael Y, Saunders TL, Wang A, Liang Y, et al. Correction of deafness in shaker-2 mice by an unconventional myosin in a BAC transgene. Science. 1998; 280: 1444–1447. pmid:9603735
- 51. Manor U, Disanza A, Grati M, Andrade L, Lin H, Di Fiore PP, et al. Regulation of stereocilia length by myosin XVa and whirlin depends on the actin-regulatory protein Eps8. Current Biology. 2011; 21: 167–172. pmid:21236676
- 52. Weber KL, Sokac AM, Berg JS, Cheney RE, Bement WM. A microtubule-binding myosin required for nuclear anchoring and spindle assembly. Nature. 2004; 431: 325–329. pmid:15372037